Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 24, 2016
Sep. 26, 2015
Cash flows from operating activities:    
Net Loss $ (446) $ (558)
Adjustments to reconcile net loss to net cash used in operating activities:    
Net gain on sale of equity interests in ATMP JV (146) 0
Equity in loss of ATMP JV 1 0
Depreciation and amortization 99 133
Provision for deferred income taxes 11 0
Stock-based compensation expense 57 47
Non-cash interest expense 11 8
Restructuring and other special charges, net 0 83
Loss on debt redemption 61 0
Fair value of warrant issued related to sixth amendment to the WSA 240 0
Other (5) 12
Changes in operating assets and liabilities:    
Accounts receivable (107) 164
Inventories (94) (93)
Prepayment and other - GLOBALFOUNDRIES 20 97
Prepaid expenses and other assets (134) (113)
Payable to ATMP JV 144 0
Payable to GLOBALFOUNDRIES 39 9
Accounts payable, accrued liabilities and other 151 (74)
Net cash used in operating activities (98) (285)
Cash flows from investing activities:    
Net proceeds from sale of equity interests in ATMP JV 346 0
Purchases of available-for-sale securities 0 (227)
Purchases of property, plant and equipment (56) (64)
Proceeds from maturities of available-for-sale securities 0 462
Proceeds from sale of property, plant and equipment 0 8
Other 3 0
Net cash provided by investing activities 293 179
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 668 0
Proceeds from issuance of convertible senior notes, net of issuance costs 681 0
Proceeds from issuance of common stock under stock-based compensation equity plans 12 1
Proceeds from (repayments of) borrowings, net (230) 100
Repayments of long-term debt (848) (44)
Other (5) (1)
Net cash provided by financing activities 278 56
Net increase (decrease) in cash and cash equivalents 473 (50)
Cash and cash equivalents at beginning of period 785 805
Cash and cash equivalents at end of period $ 1,258 $ 755